S2k guideline on diagnosis and treatment of atopic dermatitis - short version
Atopic dermatitis (AD) represents a pruritic, non-contagious, chronic or chronically relapsing, inflammatory skin disease. The course of the disease may be complicated by bacterial or viral superinfections. The first manifestation of the disease and further flare-ups are due to genetic predispositio...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2016
|
| In: |
Journal der Deutschen Dermatologischen Gesellschaft
Year: 2015, Volume: 14, Issue: 1, Pages: 92-105 |
| ISSN: | 1610-0387 |
| DOI: | 10.1111/ddg.12871 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1111/ddg.12871 Verlag, lizenzpflichtig, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1111/ddg.12871 
|
| Author Notes: | Thomas Werfel, Annice Heratizadeh, Werner Aberer, Frank Ahrens, Matthias Augustin, Tilo Biedermann, Thomas Diepgen, Regina Fölster‐Holst, Uwe Gieler, Julia Kahle, Alexander Kapp, Alexander Nast, Katja Nemat, Hagen Ott, Bernhard Przybilla, Martin Roecken, Martin Schlaeger, Peter Schmid‐Grendelmeier, Jochen Schmitt, Thomas Schwennesen, Doris Staab, Margitta Worm |
| Summary: | Atopic dermatitis (AD) represents a pruritic, non-contagious, chronic or chronically relapsing, inflammatory skin disease. The course of the disease may be complicated by bacterial or viral superinfections. The first manifestation of the disease and further flare-ups are due to genetic predisposition and also to a variety of further trigger factors. The therapy regimen should be adapted to disease symptoms that are actually present and consider individual features of the disease as reported by the patients or their parents. This short version of the German guideline on AD provides an overview of evidence-based diagnostic and treatment options. All recommendations made here are the result of a consensus of the scientific medical societies, working groups and support groups based on scientific data published to date. Abstracts and details of the studies cited are provided in the long version of this guideline (see: www.awmf.org). |
|---|---|
| Item Description: | First published 29 December 2015 |
| Physical Description: | Online Resource |
| ISSN: | 1610-0387 |
| DOI: | 10.1111/ddg.12871 |